San Antonio Breast Cancer Symposium fuels $39.6 million impact and advances in cancer care
March 31, 2026
The San Antonio Breast Cancer Symposium drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio.
UT Health San Antonio Multispecialty and Research Hospital treats first clinical trial participant in novel cancer study
March 24, 2026
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
Large rapamycin clinical trial launches at UT Health San Antonio
March 16, 2026
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
UT San Antonio School of Dentistry climbs into top 10 in national Blue Ridge Institute rankings
March 10, 2026
The University of Texas at San Antonio (UT San Antonio) School of Dentistry is ranked ninth nationally and first in Texas among all dental schools in the United States, according to the 2025 Blue Ridge Institute for Medical Research rankings. Based on …
UT San Antonio advances in national Blue Ridge rankings
March 9, 2026
In its first appearance in the national standings as a united institution, UT San Antonio posted a strong performance in the latest rankings from the Blue Ridge Institute for Medical Research. The Blue Ridge Institute is an independent nonprofit organization that compiles annual funding data from the National Institutes of Health.
UT San Antonio to lead $38 million national trial testing drugs to extend healthspan
March 4, 2026
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
Widely used metabolic drugs may help curb rising colorectal cancer in younger adults
March 2, 2026
A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.
Chronic pain research receives major NIH grant
February 27, 2026
A five-year, $9 million National Institutes of Health National Institute of Neurological Disorders and Stroke study that began in 2022 recently received approval at the three-year mark, allowing investigators to continue their work examining the biological mechanisms of TMJ disorders. The project is part of a national consortium of five institutions conducting complementary studies across the country.
Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science
February 24, 2026
Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science
UT Health San Antonio researcher earns grant to study how the brain’s immune cells might actually contribute to Alzheimer’s
February 20, 2026
Cure Alzheimer’s Fund award aimed at better understanding microglia’s role A researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure A …